1.
Fontilles, Rev. leprol
; 24(1): 15-24, ene. 2003.
Article
in Es
| IBECS
| ID: ibc-26754
ABSTRACT
No disponible
Subject(s)
Humans , Leprosy/drug therapy , Leprostatic Agents/administration & dosage , Tuberculosis/drug therapy , Antitubercular Agents/therapeutic use , Drug Therapy, Combination , Treatment Refusal , Patient Compliance , Self Administration , Personnel Management
2.
Lepr Rev
; 72(1): 3-7, 2001 Mar.
Article
in English
| MEDLINE
| ID: mdl-11355516
3.
s.l; s.n; 1997. 4 p. tab.
Non-conventional
in English
| Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1237211
Subject(s)
Anti-Infective Agents/adverse effects , Anti-Infective Agents/therapeutic use , Dapsone/therapeutic use , Drug Administration Schedule , Leprostatic Agents/adverse effects , Leprostatic Agents/therapeutic use , Leprosy, Lepromatous/pathology , Leprosy, Lepromatous/drug therapy , Ofloxacin/adverse effects , Ofloxacin/therapeutic use , Drug Therapy, Combination , Recurrence , Rifampin/adverse effects , Rifampin/therapeutic use , Follow-Up Studies
4.
s.l; s.n; 1996. 7 p. tab.
Non-conventional
in English
| Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1236913
Subject(s)
Anti-Infective Agents/administration & dosage , Anti-Infective Agents/therapeutic use , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Mice , Clarithromycin/administration & dosage , Drug Combinations , Colony Count, Microbial , Drug Administration Schedule , Leprostatic Agents/administration & dosage , Leprostatic Agents/therapeutic use , Leprosy/drug therapy , Minocycline/administration & dosage , Mycobacterium leprae , Mycobacterium leprae/growth & development , Drug Therapy, Combination/therapeutic use , Rifampin , Rifampin/therapeutic use , Tetracyclines/administration & dosage , Tetracyclines/therapeutic use
5.
s.l; s.n; 1991. 3 p. tab.
Non-conventional
in English
| Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1236378
Subject(s)
Clarithromycin , Erythromycin/administration & dosage , Erythromycin/analogs & derivatives , Erythromycin/therapeutic use , Leprosy/drug therapy , Minocycline/administration & dosage , Minocycline/therapeutic use , Mycobacterium leprae , Drug Therapy, Combination , Rifampin/therapeutic use
6.
Int J Lepr Other Mycobact Dis
; 56(2): 326-8, 1988 Jun.
Article
in English
| MEDLINE
| ID: mdl-3045229
7.
Int J Lepr Other Mycobact Dis
; 55(4 Suppl): 830-5, 1987 Dec.
Article
in English
| MEDLINE
| ID: mdl-3325575
8.
Int J Lepr Other Mycobact Dis
; 55(4 Suppl): 836-42, 1987 Dec.
Article
in English
| MEDLINE
| ID: mdl-3325576
Subject(s)
Leprostatic Agents/therapeutic use , Leprosy/drug therapy , Mycobacterium leprae/drug effects , Animals , Clofazimine/therapeutic use , Dapsone/therapeutic use , Drug Evaluation, Preclinical/methods , Mice , Mycobacterium leprae/isolation & purification , Rifampin/therapeutic use , Thioamides/therapeutic use
9.
Int J Lepr Other Mycobact Dis
; 55(4 Suppl): 807-13, 1987 Dec.
Article
in English
| MEDLINE
| ID: mdl-3125288
10.
Int J Lepr Other Mycobact Dis
; 54(1): 11-5, 1986 Mar.
Article
in English
| MEDLINE
| ID: mdl-3519796
ABSTRACT
Because of the recent spate of reports of primary resistance to dapsone among patients with lepromatous leprosy, largely to small concentrations of the drug, a survey was made of the results of dapsone-susceptibility testing of strains of Mycobacterium leprae isolated before 1977 among six laboratories which employed the mouse foot pad technique for this work prior to that time. Data have been found for strains that had been isolated from 73 patients, representing 19 countries and dependencies, with previously untreated lepromatous leprosy; all 73 strains were inhibited from multiplication by dapsone administered to mice in a concentration of 0.0001 g per 100 g mouse diet. These data suggest that the properties of M. leprae isolated from previously untreated patients with respect to susceptibility to dapsone have changed since the years preceding 1977.
Subject(s)
Dapsone/pharmacology , Leprosy/microbiology , Mycobacterium leprae/drug effects , Animals , Drug Resistance, Microbial , Humans , Mice , Mycobacterium leprae/growth & development , Mycobacterium leprae/isolation & purification , Time Factors
11.
s.l; s.n; 1985. 14 p. tab.
Non-conventional
in English, Portuguese
|
LILACS-Express
| Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1235624
12.
In. International Leprosy Congress, 12. International Leprosy Congress, 12/Proceedings. New Delhi, s.n, 1984. p.233-235.
Non-conventional
in English
|
LILACS-Express
| Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1246400
